Showing results (211-220 of 234) with videos related to
Sort By:
Pageof 24
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 14, 2017
Influence of secondary diagnoses in the development of urinary incontinence after radical prostatectomyBárbara Padilla-Fernández, Álvaro Julio Virseda-Rodríguez, Lauro Sebastián Valverde-Martínez, et al.Iscience|September 8, 2022
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicityOana Hangiu, Marta Compte, Anders Dinesen, et al.Eclinicalmedicine|August 31, 2021
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]"Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.Oncoimmunology|August 29, 2024
CD4<sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenograftsAnaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui, et al.Eclinicalmedicine|June 30, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trialAlejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.Oncoimmunology|April 28, 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor responseLaura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L Harwood, et al.The Prostate|May 7, 2025
Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate-Specific Membrane Antigen PET/CT Accuracy in Biochemical RecurrenceLaura Chamorro Castillo, Inés Rivero Belenchón, Ignacio Puche Sanz, et al.Rheumatology International|May 23, 2018
The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot studyMariano Tomás Flórez, Raquel Almodóvar, Fernando García Pérez, et al.Journal for Immunotherapy of Cancer|April 30, 2025
CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progressionJavier Arroyo-Ródenas, Aida Falgas, Laura Díez-Alonso, et al.Cancer Immunology Research|April 1, 2022
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell EngagersBelén Blanco, Ángel Ramírez-Fernández, Clara Bueno, et al.Pageof 24